09/20/2024
3:56 PM | Aurinia Pharmaceuticals (Issuer)
MacKay-Dunn R. Hector (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
3:08 PM | Aurinia Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/12/2024
3:10 PM | Aurinia Pharmaceuticals (Subject)
TANG CAPITAL MANAGEMENT LLC (Filed by)
| Form SC 13D | |
08/01/2024
5:03 AM | Aurinia Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2024
5:07 AM | Aurinia Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/14/2024
4:25 PM | Aurinia Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2024
4:25 PM | Aurinia Pharmaceuticals (Filer)
| Form DEFA14A | |
|
05/22/2024
3:14 PM | Aurinia Pharmaceuticals (Issuer)
Billen Daniel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
3:16 PM | Aurinia Pharmaceuticals (Issuer)
Balakrishnan Brinda (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
5:07 AM | Aurinia Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/02/2024
5:03 AM | Aurinia Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2024
4:23 PM | Aurinia Pharmaceuticals (Subject)
ILJIN SNT Co., Ltd. (Filed by)
| Form SC 13D/A | |
03/07/2024
3:44 PM | Aurinia Pharmaceuticals (Issuer)
Miller Joseph M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
3:46 PM | Aurinia Pharmaceuticals (Issuer)
Greenleaf Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
3:41 PM | Aurinia Pharmaceuticals (Issuer)
Robertson Stephen P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
3:42 PM | Aurinia Pharmaceuticals (Issuer)
Habig Scott Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
3:43 PM | Aurinia Pharmaceuticals (Issuer)
Donley Matthew Maxwell (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
3:10 PM | Aurinia Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/29/2024
3:11 PM | Aurinia Pharmaceuticals (Issuer)
Knappertz Volker (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
3:31 PM | Aurinia Pharmaceuticals (Issuer)
Donley Matthew Maxwell (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
3:33 PM | Aurinia Pharmaceuticals (Issuer)
Habig Scott Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
3:35 PM | Aurinia Pharmaceuticals (Issuer)
Knappertz Volker (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
3:17 PM | Aurinia Pharmaceuticals (Issuer)
Miller Joseph M (Reporting)
| Form 4/A | |
02/22/2024
3:19 PM | Aurinia Pharmaceuticals (Issuer)
Robertson Stephen P. (Reporting)
| Form 4/A | |
02/15/2024
5:06 AM | Aurinia Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/15/2024
5:16 AM | Aurinia Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
2:27 PM | ARMISTICE CAPITAL, LLC (Filed by)
Aurinia Pharmaceuticals (Subject)
| Form SC 13G | |
02/12/2024
8:41 AM | Aurinia Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
01/05/2024
5:02 AM | Aurinia Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/02/2023
5:01 AM | Aurinia Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/02/2023
5:05 AM | Aurinia Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
